Corcept Therapeutics (CORT) Total Debt Growth (1y) (2013 - 2023)
Corcept Therapeutics (CORT) Total Debt Growth (1y) (2013 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 103.99% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 3.84% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Corcept Therapeutics | 9.56 Bn | 9.22 Bn | 162.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 0.00% |
| Jun 30, 2017 | -79.49% |
| Mar 31, 2017 | -59.64% |
| Dec 31, 2016 | -46.66% |
| Sep 30, 2016 | -36.83% |
| Jun 30, 2016 | -29.05% |
| Mar 31, 2016 | -23.62% |
| Dec 31, 2015 | -18.87% |
| Sep 30, 2015 | -14.46% |
| Jun 30, 2015 | -10.27% |
| Mar 31, 2015 | -6.64% |
| Dec 31, 2014 | -3.36% |
| Sep 30, 2014 | 0.03% |
| Jun 30, 2014 | 3.38% |
| Mar 31, 2014 | 7.07% |
| Dec 31, 2013 | 10.68% |
| Sep 30, 2013 | 13.30% |